These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15512873)

  • 1. ALS trial design: expectation and reality.
    Miller RG; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():52-4. PubMed ID: 15512873
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic trials in ALS.
    Bradley W
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Apr; 4(1):6-7. PubMed ID: 12745610
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving efficiency of ALS clinical trials using lead-in designs.
    Moore DH; Miller RG
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():57-60. PubMed ID: 15512875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALS combination treatment. Drug cocktails.
    Rosenfeld J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():115-7. PubMed ID: 15512890
    [No Abstract]   [Full Text] [Related]  

  • 5. Designing clinical trials in amyotrophic lateral sclerosis.
    Shefner JM
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):495-508, ix. PubMed ID: 18625412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biopharmaceutical industry and new drugs for amyotrophic lateral sclerosis.
    Malta E
    Adv Neurol; 1995; 68():263-9; discussion 271-5. PubMed ID: 8787239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALS issues in clinical trials. Statistical issues.
    Levin B
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():43-5. PubMed ID: 15512870
    [No Abstract]   [Full Text] [Related]  

  • 8. Improving efficiency of ALS clinical trials: a sponsor's perspective.
    Markabi S; Schadrack J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S7-8. PubMed ID: 12396792
    [No Abstract]   [Full Text] [Related]  

  • 9. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
    de Carvalho M; Swash M
    Arch Neurol; 2006 Apr; 63(4):557-60. PubMed ID: 16606769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is next in ALS clinical trials?
    Sorenson EJ
    Neurology; 2007 Aug; 69(8):719-20. PubMed ID: 17709702
    [No Abstract]   [Full Text] [Related]  

  • 11. Scrutinizing enrollment in ALS clinical trials: room for improvement?
    Bedlack RS; Pastula DM; Welsh E; Pulley D; Cudkowicz ME
    Amyotroph Lateral Scler; 2008 Oct; 9(5):257-65. PubMed ID: 18608092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline disease characteristics.
    Leigh PN
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():64-7. PubMed ID: 15512877
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroprotective agents for clinical trials in ALS: systematic assessment.
    Burke WJ
    Neurology; 2007 Feb; 68(9):709; author reply 710. PubMed ID: 17325287
    [No Abstract]   [Full Text] [Related]  

  • 14. Data Safety Monitoring Board (DSMB).
    Welch KM
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():46-7. PubMed ID: 15512871
    [No Abstract]   [Full Text] [Related]  

  • 15. Sequential designs for clinical trials in amyotrophic lateral sclerosis.
    Groeneveld GJ; van der Tweel I; Wokke JH; van den Berg LH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Dec; 5(4):202-7. PubMed ID: 15799547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALS endpoints. Survival.
    Cedarbaum J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():79-83. PubMed ID: 15512880
    [No Abstract]   [Full Text] [Related]  

  • 17. An efficient multi-stage, single-arm Phase II futility design for ALS.
    Palesch YY; Tilley BC
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():55-6. PubMed ID: 15512874
    [No Abstract]   [Full Text] [Related]  

  • 18. Riluzole in amyotrophic lateral sclerosis.
    Murphy JR
    N Engl J Med; 1994 Jul; 331(4):273; author reply 273-4. PubMed ID: 8015580
    [No Abstract]   [Full Text] [Related]  

  • 19. A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis.
    Gordon PH
    Muscle Nerve; 2009 Jun; 39(6):858-60. PubMed ID: 19382169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative trial design in amyotrophic lateral sclerosis saves time and patients.
    Groeneveld GJ; Graf M; van der Tweel I; van den Berg LH; Ludolph AC
    Amyotroph Lateral Scler; 2007 Oct; 8(5):266-9. PubMed ID: 17852016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.